Decreased Flow-Dependent Dilation in Carotid Arteries of Tissue Kallikrein–Knockout Mice
- 30 March 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 88 (6) , 593-599
- https://doi.org/10.1161/01.res.88.6.593
Abstract
— Flow-dependent dilation is a fundamental mechanism by which large arteries ensure appropriate blood supply to tissues. We investigated whether or not the vascular kallikrein-kinin system, especially tissue kallikrein (TK), contributes to flow-dependent dilation by comparing wild-type and TK-knockout mice in which the presence or absence of TK expression was verified. We examined in vitro changes in the outer diameter of perfused carotid arteries from TK+/+ and TK−/− mice. In both groups, exogenous bradykinin caused a similar dilation that was abolished by the B2 receptor antagonist HOE-140, as well as by the NO synthase inhibitor Nω-nitro-l-arginine methyl ester. However, purified kininogen dilated only TK+/+ arteries, demonstrating the essential role of TK in the vascular formation of kinins. In TK+/+ arteries, increasing intraluminal flow caused a larger endothelium-dependent dilation than that seen in TK−/−. In both strains the flow response was mediated by NO and by endothelium-derived hyperpolarizing factor, whereas in TK−/− vasoconstrictor prostanoids participated as well. HOE-140 impaired flow-dependent dilation in TK+/+ arteries while showing no effect in TK−/−. This compound reduced the flow response in TK+/+ arteries to a level similar to that in TK−/−. After NO synthase inhibition, HOE-140 no longer affected the response of TK+/+. Impaired flow-dependent dilation was also observed in arteries from knockout mice lacking bradykinin B2 receptors as compared with wild-type animals. This study demonstrates the active contribution of the vascular kallikrein-kinin system to one-third of the flow-dependent dilation response via activation of B2 receptors coupled to endothelial NO release.Keywords
This publication has 27 references indexed in Scilit:
- Bradykinin-regulated Interactions of the Mitogen-activated Protein Kinase Pathway with the Endothelial Nitric-oxide SynthaseJournal of Biological Chemistry, 2000
- Endothelial Dysfunction: From Physiology to TherapyJournal of Molecular and Cellular Cardiology, 1999
- Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin.Journal of Clinical Investigation, 1997
- Bradykinin peptides in kidney, blood, and other tissues of the rat.Hypertension, 1993
- Kinins mediate kallikrein-induced endothelium-dependent relaxations in isolated canine coronary arteriesBiochemical and Biophysical Research Communications, 1992
- Kinins and Endothelium-Dependent Relaxations to Converting Enzyme Inhibitors in Perfused Canine ArteriesJournal of Cardiovascular Pharmacology, 1991
- Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.Hypertension, 1991
- Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity.Journal of Clinical Investigation, 1990
- Crucial role of endothelium in the vasodilator response to increased flow in vivo.Hypertension, 1986
- Kininogen substrates for trypsin and cathepsin D in human, rabbit and rat plasmasLife Sciences, 1983